Compared to the T2DM group, the T2DM + AMI group had a significantly higher proportion of males and previous history of smoking and hypertension, higher levels of fasting blood glucose, serum creatinine, TC, LDL-C, hs-CRP, HbA1c, CK-MB, and cTNI, lower HDL-C level and lower prior treatment with statins, angiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB), and metformin. This evidence concerns the gene CRP and type 2 diabetes mellitus.